We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$851B
AUM Growth
+$80.9B
Cap. Flow
+$19.9B
Cap. Flow %
2.34%
Top 10 Hldgs %
25.93%
Holding
4,889
New
83
Increased
3,362
Reduced
611
Closed
132

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.18B
2
AAPL icon
Apple
AAPL
+$1.11B
3
AVGO icon
Broadcom
AVGO
+$562M
4
AMZN icon
Amazon
AMZN
+$553M
5
PANW icon
Palo Alto Networks
PANW
+$485M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 13.33%
3 Financials 12.09%
4 Consumer Discretionary 10.85%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GYRE icon
4351
Gyre Therapeutics
GYRE
$641M
$94.9K ﹤0.01%
18,002
SLN
4352
Silence Therapeutics
SLN
$495M
$94.6K ﹤0.01%
17,207
+2,520
+17% +$15.2K
SRZN icon
4353
Surrozen
SRZN
$258M
$94.6K ﹤0.01%
11,463
EVLO
4354
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$94.5K ﹤0.01%
29,072
-1,362
-4% -$4.05K
POLA icon
4355
Polar Power
POLA
$5.93M
$94.2K ﹤0.01%
10,276
IGC icon
4356
IGC Pharma
IGC
$26M
$94.1K ﹤0.01%
302,140
SQFT icon
4357
Presidio Property Trust
SQFT
$2.84M
$93.7K ﹤0.01%
10,377
UPH
4358
DELISTED
UpHealth, Inc.
UPH
$93.4K ﹤0.01%
49,676
RSKD icon
4359
Riskified
RSKD
$694M
$92.8K ﹤0.01%
19,093
+4,859
+34% +$24.4K
PETV
4360
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$92.7K ﹤0.01%
47,045
AKU
4361
DELISTED
Akumin Inc
AKU
$92.6K ﹤0.01%
514,401
ELYS
4362
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$92.5K ﹤0.01%
241,087
INDP icon
4363
Indaptus Therapeutics
INDP
$172M
$92.5K ﹤0.01%
1,804
CLRB icon
4364
Cellectar Biosciences
CLRB
$20.5M
$91.4K ﹤0.01%
1,562
-13
-0.8% -$626
ONCY
4365
Oncolytics Biotech
ONCY
$89.9M
$90.1K ﹤0.01%
34,659
ARQQ icon
4366
Arqit Quantum
ARQQ
$298M
$90.1K ﹤0.01%
2,979
+288
+11% +$8.7K
HOLO icon
4367
MicroCloud Hologram
HOLO
$33.9M
$89.9K ﹤0.01%
4
MLGO
4368
MicroAlgo
MLGO
$44.5M
$89.9K ﹤0.01%
7
CDIO icon
4369
Cardio Diagnostics
CDIO
$4.62M
$89.8K ﹤0.01%
2,516
+40
+2% +$2.26K
XELB icon
4370
Xcel Brands
XELB
$7.27M
$89.4K ﹤0.01%
5,107
VCNX
4371
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$89.1K ﹤0.01%
1,191
ACER
4372
DELISTED
Acer Therapeutics Inc
ACER
$89K ﹤0.01%
96,330
CEI
4373
DELISTED
Camber Energy, Inc
CEI
$88.7K ﹤0.01%
139,139
+64,317
+86% +$76.8K
LNAI
4374
Lunai Bioworks
LNAI
$8.8M
$88.3K ﹤0.01%
1,948
-2,038
-51% -$156K
TFFP
4375
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$88.3K ﹤0.01%
7,515

Similar funds

Geode Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
  • Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
  • Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
  • Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
  • Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
  • Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.